{"id":45692,"date":"2026-01-22T13:10:41","date_gmt":"2026-01-22T13:10:41","guid":{"rendered":"https:\/\/ciaoup.it\/?p=45692"},"modified":"2026-01-22T13:10:41","modified_gmt":"2026-01-22T13:10:41","slug":"ce-mark-for-new-diameter-range-for-the-gore-viatorr-tips-endoprosthesis-with-controlled-expansion","status":"publish","type":"post","link":"https:\/\/ciaoup.it\/?p=45692","title":{"rendered":"CE MARK FOR NEW DIAMETER RANGE FOR THE GORE\u00ae VIATORR\u00ae TIPS ENDOPROSTHESIS WITH CONTROLLED EXPANSION"},"content":{"rendered":"<p>COMUNICATO STAMPA &#8211; CONTENUTO PROMOZIONALE<\/p>\n<p> Trusted TIPS device is the first approved to offer a 6-10 mm diameter range, delivering greater control to physicians treating portal hypertension.\u00a0<\/p>\n<p>PUTZBRUNN, Germany, Jan. 22, 2026 \/PRNewswire\/ &#8212;\u00a0W. L. Gore &amp; Associates Medical Products (Gore) today announced CE mark approval of the new 6-10 mm diameter range for the GORE\u00ae VIATORR\u00ae TIPS Endoprosthesis with Controlled Expansion.\u00a0<\/p>\n<p>Building on more than 25 years of innovation in portal hypertension, the expanded diameter range offers physicians flexibility to customize treatment based on individual patient needs, with the confidence that comes from Gore&#8217;s controlled expansion technology.\u00a0<\/p>\n<p>A\u00a0legacy of lasting control\u00a0\u00a0<\/p>\n<p>The VIATORR\u00ae Device enables consistent, tailored control of the shunt diameter to achieve a targeted portal pressure gradient. Previously approved with an 8\u201310 mm diameter range, the latest device iteration gives clinicians more options when balancing a desired portal pressure gradient and the risks associated with over shunting.\u00a0\u00a0<\/p>\n<p>&#8220;My research and clinical experience conducted with Professor F. Vizzutti\u00a0have consistently shown that\u00a0optimizing\u00a0shunt diameter is critical for improving outcomes in portal hypertension. Smaller-diameter devices may significantly reduce complications such as hepatic encephalopathy and cardiac overload. The VIATORR\u00ae Device with controlled expansion technology represents an important evolution, enabling precise tailoring of shunt size to individual patient needs. This is not just a technical refinement \u2013 it could provide a meaningful improvement for those living with portal hypertension.&#8221; Professor Filippo Schepis. Head of Hepatic Hemodynamic Lab at the University Hospital of Modena, Italy.\u00a0<\/p>\n<p>Long term performance, proven over time\u00a0\u00a0<\/p>\n<p>The VIATORR\u00ae Device\u00a0remains\u00a0the only covered TIPS device with more than two decades of clinical performance and over 500 publications supporting\u00a0a track record\u00a0of patency and reliability. Constructed using Gore&#8217;s proprietary\u00a0ePTFE\u00a0graft lining, the device is designed to resist bile and mucin permeation \u2014 common causes of patency loss in TIPS.\u00a0\u00a0<\/p>\n<p>&#8220;The introduction of [GORE\u00ae VIATORR\u00ae TIPS Endoprosthesis with Controlled Expansion] with diameters ranging from 6 to 10 mm, into clinical practice is expected to represent a significant advancement in the management of patients with complications of portal hypertension. It\u00a0is now well established that small diameter TIPS can achieve effective portal pressure gradient reduction while substantially lowering the risk of cardiac overload and hepatic\u00a0encephalopathy. The availability of such devices will allow for a more tailored approach to shunt calibration, optimizing portal decompensation while minimizing systemic repercussions&#8221; said Roberto Miraglia, ISMETT, Palermo, Italy.\u00a0\u00a0<\/p>\n<p>Balancing outcomes with care\u00a0\u00a0<\/p>\n<p>TIPS procedures require a careful balance: too much shunting can lead to complications like hepatic encephalopathy and right heart overload, while too little may not sufficiently relieve the complications of portal hypertension.\u00a0\u00a0<\/p>\n<p>&#8220;The controlled expansion technology built on the VIATORR\u00ae [Device] legacy of predictable performance&#8221;\u00a0said Thomas Wiersma, EMEA Product Specialist, Gore Medical Product Division.&#8221;Now, with a broader diameter range in one single device, we&#8217;re not only improving control during implantation \u2014 we also deliver more options to physicians without increasing inventory.&#8221;\u00a0\u00a0<\/p>\n<p>To learn more about the VIATORR\u00ae Device, including long-term patency and outcomes compared to non-TIPS therapy, visit goremedical.com\/en-emea\/products\/viatorr<br \/>\n\u00a0<\/p>\n<p>Medical Products\u00a0\u00a0<\/p>\n<p>Gore\u00a0engineers\u00a0medical devices that treat a range of cardiovascular and other health conditions. With more than 55 million medical devices implanted over the course of more than 45 years, Gore builds on its legacy of improving patient outcomes through research,\u00a0education\u00a0and quality initiatives. Product performance, ease of use and quality of service provide sustainable cost savings for physicians,\u00a0hospitals\u00a0and insurers. Gore is joined in service with clinicians and through this collaboration we are improving lives. For more information, visit\u00a0https:\/\/www.goremedical.com\/en-emea<br \/>\n\u00a0<\/p>\n<p>About Gore\u00a0<\/p>\n<p>W. L. Gore &amp; Associates is a global materials science company dedicated to transforming industries and improving lives. Since 1958, Gore has solved complex technical challenges in demanding environments\u2014from outer space to the world&#8217;s highest peaks to the inner workings of the human body. With approximately 13,000 Associates and a strong, team-oriented culture.\u00a0\u00a0<\/p>\n<p>gore.com\u00a0<\/p>\n<p>Consult Instructions for Useeifu.goremedical.com\u00a0<\/p>\n<p>Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx Only<br \/>\n\u00a0<\/p>\n<p>Products listed may not be available in all markets.\u00a0<\/p>\n<p>Photo &#8211; https:\/\/mma.prnewswire.com\/media\/2860703\/WL_Gore_TIPS_Endoprosthesis.jpgLogo &#8211; https:\/\/mma.prnewswire.com\/media\/1633961\/W_L_Gore_Associates_Logo.jpg<br \/>\n\u00a0<\/p>\n<p> View original content:https:\/\/www.prnewswire.co.uk\/news-releases\/ce-mark-for-new-diameter-range-for-the-gore-viatorr-tips-endoprosthesis-with-controlled-expansion-302663286.html<br \/>\n\u00a0<\/p>\n<p>Copyright 2026 PR Newswire. All Rights Reserved.\u00a0<\/p>\n<p>COMUNICATO STAMPA &#8211; CONTENUTO PROMOZIONALE: Immediapress &#232; un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall&#8217;ente che lo emette. L&#8217;Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi<\/p>\n<p>&#8212;<\/p>\n<p>immediapress<\/p><\/p>\n<div style=\"display:flex; gap:10px;justify-content:center\" class=\"wps-pgfw-pdf-generate-icon__wrapper-frontend\">\n\t\t<a  href=\"https:\/\/ciaoup.it?action=genpdf&amp;id=45692\" class=\"pgfw-single-pdf-download-button\" ><img src=\"https:\/\/ciaoup.it\/wp-content\/plugins\/pdf-generator-for-wp\/admin\/src\/images\/PDF_Tray.svg\" title=\"Generate PDF\" style=\"width:auto; height:45px;\"><\/a>\n\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>COMUNICATO STAMPA &#8211; CONTENUTO PROMOZIONALE Trusted TIPS device is the first approved to offer a&hellip;<\/p>\n","protected":false},"author":3,"featured_media":45693,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[23],"class_list":["post-45692","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-comunicati","tag-immediapress"],"_links":{"self":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts\/45692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45692"}],"version-history":[{"count":1,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts\/45692\/revisions"}],"predecessor-version":[{"id":45717,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts\/45692\/revisions\/45717"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/media\/45693"}],"wp:attachment":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}